Antibiotics for Bacterial Vaginosis or Trichomonas vaginalis in Pregnancy: A Systematic Review
- 1 April 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (4) , 857-868
- https://doi.org/10.1097/01.aog.0000157108.32059.8f
Abstract
To determine whether antibiotic treatment for bacterial vaginosis or Trichomonas vaginalis during pregnancy decreases the risk of preterm birth and associated adverse outcomes. Pre-MEDLINE and MEDLINE (1966-2003), EMBASE (1980-2003), and the Cochrane Library were searched using the keywords "bacterial vaginosis", "Trichomonas", "Trichomonas vaginalis", "Trichomonas vaginitis", "Trichomonas infections", "pregnancy", "pregnant", "antibiotics", and "antibiotic prophylaxis". The search produced 1,888 titles, of which 1,256 abstracts were reviewed further. Of these, 1,217 were ineligible. Inclusion criteria were the following: randomized controlled trials in which antibiotics were compared with no antibiotic or placebo, for women in the second or third trimester of pregnancy with symptomatic or asymptomatic bacterial vaginosis or Trichomonas vaginalis, intact membranes, and not in labor. Exclusion criteria were as follows: published in a language other than English, dropout rate of more than 20% of women in either group, and lack of usable outcomes. Of the 39 papers reviewed in detail, 14 studies were included in the meta-analysis. One of the authors reviewed titles obtained from the searches, and 2 reviewers independently reviewed the abstracts, excluded those that were ineligible, identified eligible papers, and abstracted the data. For women with bacterial vaginosis, antibiotics reduced the risk of persistent infection but did not reduce the risk of preterm birth or the incidence of associated adverse outcomes for the general population or for any subgroup analyzed. For women with Trichomonas vaginalis, metronidazole reduced the risk of persistent infection but increased the incidence of preterm birth. Contrary to the conclusions of 3 recent systematic reviews, we found no evidence to support the use of antibiotic treatment for bacterial vaginosis or Trichomonas vaginalis in pregnancy to reduce the risk of preterm birth or its associated morbidities in low- or high-risk women.Keywords
This publication has 43 references indexed in Scilit:
- Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract floraObstetrics & Gynecology, 2003
- Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial*1Obstetrics & Gynecology, 2001
- Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial VaginosisNew England Journal of Medicine, 2000
- Trichomonas vaginalis Associated With Low Birth Weight and Preterm DeliverySexually Transmitted Diseases, 1997
- Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial VaginosisNew England Journal of Medicine, 1995
- Intravaginal clindamycin treatment for bacterial vaginosis: Effects on preterm delivery and low birth weightAmerican Journal of Obstetrics and Gynecology, 1995
- Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluationAmerican Journal of Obstetrics and Gynecology, 1995
- Outcome of the vaginal infections and prematurity study: Results of a clinical trial of erythromycin among pregnant women colonized with group B streptococciAmerican Journal of Obstetrics and Gynecology, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Spontaneous early preterm labour associated with abnormal genital bacterial colonizationBJOG: An International Journal of Obstetrics and Gynaecology, 1986